These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7731384)

  • 1. The vaginal epithelium in the postmenopause--cytology, histology and pH as methods of assessment.
    Nilsson K; Risberg B; Heimer G
    Maturitas; 1995 Jan; 21(1):51-6. PubMed ID: 7731384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen effects on the vaginal pH, flora and cytology in late postmenopause after a long period without hormone therapy.
    Galhardo CL; Soares JM; Simões RS; Haidar MA; Rodrigues de Lima G; Baracat EC
    Clin Exp Obstet Gynecol; 2006; 33(2):85-9. PubMed ID: 16903243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry.
    van der Laak JA; de Bie LM; de Leeuw H; de Wilde PC; Hanselaar AG
    J Clin Pathol; 2002 Jun; 55(6):446-51. PubMed ID: 12037029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose (0.3 mg) synthetic conjugated estrogens A is effective for managing atrophic vaginitis.
    Marx P; Schade G; Wilbourn S; Blank S; Moyer DL; Nett R
    Maturitas; 2004 Jan; 47(1):47-54. PubMed ID: 14706765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
    Kagan R; Williams RS; Pan K; Mirkin S; Pickar JH
    Menopause; 2010 Mar; 17(2):281-9. PubMed ID: 19779382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy.
    Freedman M; Kaunitz AM; Reape KZ; Hait H; Shu H
    Menopause; 2009; 16(4):735-41. PubMed ID: 19252451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year treatment persistence with local estrogen therapy in postmenopausal women diagnosed as having vaginal atrophy.
    Portman D; Shulman L; Yeaw J; Zeng S; Uzoigwe C; Maamari R; Iyer NN
    Menopause; 2015 Nov; 22(11):1197-203. PubMed ID: 25944522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial.
    Fernandes T; Costa-Paiva LH; Pedro AO; Baccaro LF; Pinto-Neto AM
    Menopause; 2016 Jul; 23(7):792-8. PubMed ID: 27116462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.
    Simon JA; Reape KZ; Wininger S; Hait H
    Fertil Steril; 2008 Oct; 90(4):1132-8. PubMed ID: 18053998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cigarette smoking and the degree of maturation of the vaginal squamous epithelium in postmenopausal women.
    Karamanidis D; Tamiolakis D; Koutsougeras G; Tripsanas CH; Retzos K; Karidis S; Liberis B
    Clin Exp Obstet Gynecol; 2001; 28(4):274-6. PubMed ID: 11838758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial.
    Portman D; Palacios S; Nappi RE; Mueck AO
    Maturitas; 2014 Jun; 78(2):91-8. PubMed ID: 24679891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic effects of conjugated equine estrogen vaginal cream on bone turnover markers in postmenopausal women.
    Luengratsameerung S; Panyakhamlerd K; Treratanachat S; Taechakraichana N
    Climacteric; 2013 Feb; 16(1):133-40. PubMed ID: 22515801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravaginally applied oxytocin improves post-menopausal vaginal atrophy.
    Al-Saqi SH; Uvnäs-Moberg K; Jonasson AF
    Post Reprod Health; 2015 Sep; 21(3):88-97. PubMed ID: 25995333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin improves cytological and histological profiles of vaginal atrophy in postmenopausal women.
    Al-Saqi SH; Jonasson AF; Naessén T; Uvnäs-Moberg K
    Post Reprod Health; 2016 Mar; 22(1):25-33. PubMed ID: 26883689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial.
    Lima SM; Bernardo BF; Yamada SS; Reis BF; da Silva GM; Galvão MA
    Maturitas; 2014 Jul; 78(3):205-11. PubMed ID: 24856055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D Proliferates Vaginal Epithelium through RhoA Expression in Postmenopausal Atrophic Vagina tissue.
    Lee A; Lee MR; Lee HH; Kim YS; Kim JM; Enkhbold T; Kim TH
    Mol Cells; 2017 Sep; 40(9):677-684. PubMed ID: 28843271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Foeniculum vulgare (fennel) vaginal cream on vaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled trial.
    Yaralizadeh M; Abedi P; Najar S; Namjoyan F; Saki A
    Maturitas; 2016 Feb; 84():75-80. PubMed ID: 26617271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy.
    Constantine GD; Simon JA; Pickar JH; Archer DF; Kushner H; Bernick B; Gasper G; Graham S; Mirkin S;
    Menopause; 2017 Apr; 24(4):409-416. PubMed ID: 27922936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postpartum vaginal atrophy.
    Wisniewski PM; Wilkinson EJ
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1249-54. PubMed ID: 1659199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy.
    Ayton RA; Darling GM; Murkies AL; Farrell EA; Weisberg E; Selinus I; Fraser ID
    Br J Obstet Gynaecol; 1996 Apr; 103(4):351-8. PubMed ID: 8605133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.